Highlights and Quick Summary
- SG&A Expenses for the quarter ending September 30, 2022 was $7.25 Million (a -10.28% decrease compared to previous quarter)
- Year-over-year quarterly SG&A Expenses decreased by -0.81%
- Annual SG&A Expenses for 2021 was $32 Million (a 19.08% increase from previous year)
- Annual SG&A Expenses for 2020 was $26.8 Million (a 50.37% increase from previous year)
- Annual SG&A Expenses for 2019 was $17.8 Million (a 152.76% increase from previous year)
- Twelve month SG&A Expenses ending September 30, 2022 was $31.2 Million (a -4.72% decrease compared to previous quarter)
- Twelve month trailing SG&A Expenses decreased by -2.25% year-over-year
Trailing SG&A Expenses for the last four month:
30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
---|---|---|---|
$31.2 Million | $32.8 Million | $32.7 Million | $32 Million |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical SG&A Expenses of Atreca, Inc.
Most recent SG&A Expensesof BCEL including historical data for past 10 years.Interactive Chart of SG&A Expenses of Atreca, Inc.
Atreca, Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $7.25 | $8.08 | $8.61 | – |
2021 | $7.31 | $8.8 | $8.03 | $7.82 | $31.95 |
2020 | $6.64 | $6.61 | $6.46 | $7.12 | $26.83 |
2019 | $6.93 | $4.86 | $3.54 | $2.52 | $17.85 |
2018 | – | – | $1.88 | $1.63 | $7.06 |
2017 | – | – | – | – | $4.56 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology